Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloDerm with or without Emdogain for root coverage
NCT05565079Phase 4Completed
- Sponsor
- University of Louisville
- Start
- Oct 2022
- Primary completion
- Oct 2024
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 4 trial of enamel matrix derivative in gingival recession, sponsored by University of Louisville. Started Oct 2022; status: completed.
02
Drugs
enamel matrix derivative
03
Conditions
gingival recession
Beyond the preview
Go deeper on NCT05565079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05565079.